# Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-

> **NCT06937996** · — · RECRUITING · sponsor: **Englewood Hospital and Medical Center** · enrollment: 25 (estimated)

## Conditions studied

- Pancreatic Cancer Non-resectable

## Interventions

- **DEVICE:** NanoKnife

## Key facts

- **NCT ID:** NCT06937996
- **Lead sponsor:** Englewood Hospital and Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-13
- **Primary completion:** 2035-05-31
- **Final completion:** 2035-05-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06937996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06937996, "Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06937996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*